InvestorsHub Logo
icon url

exwannabe

05/21/22 11:50 AM

#476933 RE: extrooper #476931

I am amazed that any one of the conference large pharma attendees could attend the conference and not be in a meeting discussing terms of buyout or partnership.


Why?

The NYAS treatment data itself is clearly worse than the 2018 JTM paper (and LP SNO update) would have led anybody to expect..

If they have ignored it for 4 years, why act now?
icon url

Bob_LobLaw

05/21/22 11:51 AM

#476934 RE: extrooper #476931

Very possible though there were other talks that day that were non NWBO related
icon url

Realcool11

05/21/22 12:00 PM

#476938 RE: extrooper #476931

If that happened we wouldn’t know.